132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: Co-morbidity and Treatment Effectiveness Poster Session
4094.0: Tuesday, November 9, 2004: 12:30 PM-2:00 PM
Co-morbidity and Treatment Effectiveness Poster Session
Learning Objectives: See individual abstracts.
Board 1Drug use and suicidal ideation: Gender differences from a cross sectional study
S. Hope Gilbert, PhD, Carl A Latkin, PhD
Board 2Patterns, predictors, and co-occurrence of adolescent drug involvement and suicide risk
Elaine Walsh, PhD, Elaine Adams Thompson, PhD, RN, Jerald R. Herting, PhD, Brooke P. Randell, DNSc, CS
Board 3Marijuana use trajectories and adult comorbid conditions: Results from a longitudinal study
Valerie Johnson, PhD, Robert J. Pandina, PhD, Steven Buyske, PhD
Board 4Mental health and substance abuse treatment and recent alcohol use among alcohol dependent individuals
Katherine, M. Harris, PhD
Board 5Serious mental illness among parents: Implications for adolescent substance use
Mindy Herman-Stahl, PhD, Rebecca Sanchez, PhD, Michael Penne, MPH, David Weitzenkamp, PhD, Karl Bauman, PhD, Eric Grau, PhD, Olivia Silber Ashley, DrPH, Joseph Gfroerer, BA
Board 6Need for health care services among heroin sniffers
Dale D. Chitwood, PhD, Jesus Sanchez, PhD
Board 7Childhood sexual abuse: Escaping into medication of symptoms with drugs
Celeste Patton
Board 8Key outcomes of women with co-occurring substance abuse and mental health disorders and histories of trauma receiving integrated, trauma-informed services in Massachusetts: Results of the WELL Project
Norma Finkelstein, PhD, Laurie S. Markoff, PhD, Nina Kammerer, PhD, MPH, Peter Kreiner, PhD, Lee Panas, MS
Board 9Addiction treatment workforce: Counselor credentials, training and turnover
J. Aaron Johnson, PhD, Lori J. Ducharme, PhD, Sarah Henderson, MA
Board 10Quality management in drug treatment: Measuring quality and affecting change
vg Kaynak, Robert Forman, PhD, J. Aaron Johnson, PhD, Sarah Henderson, MA
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs
Endorsed by:Mental Health

The 132nd Annual Meeting (November 6-10, 2004) of APHA